From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
|Articles|October 5, 2021
Pharmacy Clinical Pearl of the Day: Cold Symptoms vs Flu Symptoms
Author(s)Saro Arakelians, PharmD
With the arrival of flu and cold season, note the differences between symptoms for both illnesses.
Advertisement
Clinical Pearl of the Day: Cold vs Flu
Insight:
Cold symptoms
- Fever is rare
- Aches and pain are slight
- Symptoms are gradual
- Sneezing is common
- Stuffy nose is common
- Headaches are rare
- Fatigue and weakness sometimes
- Sore throat common
Flu symptoms
- Fever and chills are common
- Aches and pains are usual
- Symptoms are abrupt
- Sneezing occurs sometimes
- Stuffy nose occurs sometimes
- Headaches are common
- Fatigue and weakness are typical
- Sore throat occurs sometimes
Sources:
Advertisement
Related to this article
Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
2
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
Glucose Monitoring: Timing Makes Every Reading Count
5